Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
Al Jurdi$n$ et al., American Journal of Transplantation, doi:10.1111/ajt.17128
https://c19early.org/aljurdi.html